Clinical Trials in Nashville

Showing 5701-5720 of 20,298 trials

Effects of a Patient Portal Intervention to Address Diabetes Care Gaps

NCT04894903

The purpose of this study is to evaluate the effect of a novel patient portal intervention on the number of patients with diabetes care gaps (e.g., no diabetes eye exam i the last 12 months). The intervention is designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring \& preventative care (e.g., annual urine microalbumin) are due and (b) allow patients to initiate orders for the care.

Diabetes Mellitus

Vanderbilt University Medical Center440 participantsStarted Apr 2022

Nashville, Tennessee, United States

TERMINATEDPhase 3< 1 mile

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

NCT03192215

Objectives * Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic stroke and atrial cardiopathy. * Secondary: To test the hypothesis that the relative efficacy of apixaban over aspirin increases with the severity of atrial cardiopathy.

Stroke

Columbia University1,015 participantsStarted Jan 2018

Birmingham, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +174 more locations

Effects of a Patient Portal Intervention to Address Diabetes Care Gaps

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Find Trials by Condition in Nashville

Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

AI Ready and Exploratory Atlas for Diabetes Insights

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors

Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

Study of WAL0921 in Patients With Glomerular Kidney Diseases

An Innovative Treatment for Cervical Precancer (UH3)